GB9220921D0 - Polyamine derivatives as anticytomegaloviral agents - Google Patents

Polyamine derivatives as anticytomegaloviral agents

Info

Publication number
GB9220921D0
GB9220921D0 GB929220921A GB9220921A GB9220921D0 GB 9220921 D0 GB9220921 D0 GB 9220921D0 GB 929220921 A GB929220921 A GB 929220921A GB 9220921 A GB9220921 A GB 9220921A GB 9220921 D0 GB9220921 D0 GB 9220921D0
Authority
GB
United Kingdom
Prior art keywords
anticytomegaloviral
agents
polyamine derivatives
polyamine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929220921A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Priority to GB929220921A priority Critical patent/GB9220921D0/en
Publication of GB9220921D0 publication Critical patent/GB9220921D0/en
Priority to EP93921461A priority patent/EP0662829A1/en
Priority to JP6509077A priority patent/JPH08512279A/ja
Priority to KR1019950701292A priority patent/KR950703335A/ko
Priority to CA002146319A priority patent/CA2146319A1/en
Priority to PCT/US1993/008517 priority patent/WO1994007480A1/en
Priority to HU9500982A priority patent/HUT72663A/hu
Priority to NZ256254A priority patent/NZ256254A/en
Priority to AU48547/93A priority patent/AU4854793A/en
Priority to NO951299A priority patent/NO951299L/no
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/14—Amines containing amino groups bound to at least two aminoalkyl groups, e.g. diethylenetriamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
GB929220921A 1992-10-05 1992-10-05 Polyamine derivatives as anticytomegaloviral agents Pending GB9220921D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB929220921A GB9220921D0 (en) 1992-10-05 1992-10-05 Polyamine derivatives as anticytomegaloviral agents
AU48547/93A AU4854793A (en) 1992-10-05 1993-09-10 Polyamine derivatives as anti-cytomegaloviral agents
CA002146319A CA2146319A1 (en) 1992-10-05 1993-09-10 Polyamine derivatives as anti-cytomegaloviral agents
JP6509077A JPH08512279A (ja) 1992-10-05 1993-09-10 抗サイトメガロウイルス剤としてのポリアミン誘導体類
KR1019950701292A KR950703335A (ko) 1992-10-05 1993-09-10 항시토메갈로비루스제로서의 폴리아민 유도체(Polyamine Derivatives as Anti-Cytomegaloviral Agents)
EP93921461A EP0662829A1 (en) 1992-10-05 1993-09-10 Polyamine derivatives as anti-cytomegaloviral agents
PCT/US1993/008517 WO1994007480A1 (en) 1992-10-05 1993-09-10 Polyamine derivatives as anti-cytomegaloviral agents
HU9500982A HUT72663A (en) 1992-10-05 1993-09-10 Pharmaceutical compositions containing polyamine derivatives as anticytomegaloviral agents
NZ256254A NZ256254A (en) 1992-10-05 1993-09-10 Polyamines as anti-cytomegaloviral agents
NO951299A NO951299L (no) 1992-10-05 1995-04-04 Polyaminderivater som anti-cytomegalovirale midler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929220921A GB9220921D0 (en) 1992-10-05 1992-10-05 Polyamine derivatives as anticytomegaloviral agents

Publications (1)

Publication Number Publication Date
GB9220921D0 true GB9220921D0 (en) 1992-11-18

Family

ID=10722983

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929220921A Pending GB9220921D0 (en) 1992-10-05 1992-10-05 Polyamine derivatives as anticytomegaloviral agents

Country Status (9)

Country Link
EP (1) EP0662829A1 (ja)
JP (1) JPH08512279A (ja)
KR (1) KR950703335A (ja)
AU (1) AU4854793A (ja)
CA (1) CA2146319A1 (ja)
GB (1) GB9220921D0 (ja)
HU (1) HUT72663A (ja)
NZ (1) NZ256254A (ja)
WO (1) WO1994007480A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831001A (en) * 1990-10-24 1998-11-03 Allelix Biopharmaceuticals Inc. Treatment of herpesvirus infection
WO1995009832A1 (en) * 1993-10-07 1995-04-13 Merrell Dow Pharmaceuticals Inc. Novel process for preparing polyamine derivatives and intermediates thereof
FR2749845B1 (fr) * 1996-06-18 1998-08-21 Oreal Nouveaux derives benzyl substitue(s) de polyalkylene-polyamines et leur utilisation dans des compositions cosmetiques et pharmaceutiques
WO2003013245A1 (en) 2001-08-07 2003-02-20 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
CA2463771A1 (en) 2001-10-16 2003-04-24 Slil Biomedical Corporation Oligoamine compounds and derivatives thereof for cancer therapy
CN111989316B (zh) * 2018-01-30 2023-09-08 潘贝拉治疗股份有限公司 用于生产(6s,15s)-3,8,13,18-四氮杂二十烷-6,15-二醇的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA903804B (en) * 1989-05-23 1991-03-27 Merrell Dow Pharma A method of potentiating cell-mediated immunity utilizing polyamine derivatives

Also Published As

Publication number Publication date
KR950703335A (ko) 1995-09-20
AU4854793A (en) 1994-04-26
HUT72663A (en) 1996-05-28
HU9500982D0 (en) 1995-06-28
CA2146319A1 (en) 1994-04-14
WO1994007480A1 (en) 1994-04-14
EP0662829A1 (en) 1995-07-19
JPH08512279A (ja) 1996-12-24
NZ256254A (en) 1997-04-24

Similar Documents

Publication Publication Date Title
PL307812A1 (en) Substituted thiazolydinone derivatives
GB9305306D0 (en) Pyrrolo-pyridazione derivatives
HU9301955D0 (en) Benzophenone-hydrazone derivatives
HU9300744D0 (en) 2-oxo-quinoline derivatives
HU9500330D0 (en) Amide derivatives
ZA932639B (en) Propenoyl-imidazole derivatives
HU9301616D0 (en) New thio-semicarbazone derivatives
HU9500982D0 (en) Polyamine derivatives as anticytomegaloviral agents
GB9110722D0 (en) Amine derivatives
GB9320940D0 (en) Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative agents
EP0581165A3 (en) Acrylamide derivatives as antirussive agent
GB2270913B (en) Chlordifluoromethoxyphenyl derivatives
GB2271564B (en) Thioalkylthio carbacephalosporin derivatives
HU9300556D0 (en) Substituted phenyl-quinazoline derivatives
EP0565961A3 (en) Ethyl-triazolyl derivatives
GB9223244D0 (en) Phenylpyrazine derivatives
HU9302058D0 (en) Thia-diazinone derivatives
GB2274282B (en) Piperazine-and piperidine-isoxazole derivatives
ZA945327B (en) Azalicyclooctane derivatives as anti-arrhythmic agents
EP0578560A3 (en) Amido-alcohol derivatives as psychotropic agents
GB9304440D0 (en) 2-acyloxycephem derivatives
GB9225472D0 (en) Amine derivatives
HU9301696D0 (en) Pyrimidofuroxane derivatives
HU9202008D0 (en) New 4-methyl-2-imidazolinone derivatives
GB9311613D0 (en) Thienylthiazole derivatives